News and Updates

The global stem cell therapy market is set to reach $3.65B. Discover the key innovations and market trends driving this rapid growth in regenerative medicine.

Teva has submitted an NDA for ecopipam, a novel D1 receptor antagonist, to treat pediatric Tourette syndrome. Learn about this potential new therapy.

Experts urge the FDA to create a dedicated regulatory pathway for vaccine-based dementia prevention trials to accelerate breakthroughs in neuro-immunology.

The USFDA has approved CAPVAXIVE for children and teens at high risk of pneumococcal disease. Learn about this new vaccine's role in pediatric prevention.

New research reveals that paid paternity leave significantly lowers depression and stress in new fathers, fostering stronger family health and wellbeing.

New data confirms zero cervical cancer deaths in women vaccinated against HPV in England, highlighting the life-saving impact of immunization programs.

HHS has mandated critical safety label updates for testosterone therapy drugs to improve patient safety, clinical monitoring, and reduce misuse risks.

Discover how new clinical trial standards for HCC are set to improve research design, patient outcomes, and the development of breakthrough liver cancer drugs.

A new clinical study reveals that the probiotic Lactiplantibacillus plantarum KABP051 improves metabolic markers and boosts mood through the gut-brain axis.

UniQure is moving toward FDA approval for its Huntington’s gene therapy, AMT-130, following a major regulatory breakthrough in treating the rare condition.